Nutrients, Vol. 17, Pages 763: Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial
Nutrients, Vol. 17, Pages 763: Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial Nutrients doi: 10.3390/nu17050763 Authors: Chang Kyo Oh Hwe Hoon Chung Yu Jin Kim Jin Bae Kim Background/Objective: Rifaximin is a nonabsorbable antibiotic used to treat irritable bowel syndrome (IBS). Recent studies
